FDA To Get More Reg Science Funds In Emergency Countermeasures Initiative
This article was originally published in The Gray Sheet
Executive Summary
FDA's initiative to improve regulatory science is slated to receive $170 million in funding as part of a government-wide effort to overhaul the system for developing and producing medical countermeasures to address public health emergencies